Lista de obras - Joseph A O'Donoghue - Dominio Público Uruguay

(124)I-huA33 antibody PET of colorectal cancer.

artículo científico publicado en 2011

124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.

artículo científico publicado en 2011

18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.

artículo científico publicado en 2011

89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo

artículo científico publicado en 2019

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

artículo científico publicado en 2015

A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.

artículo científico publicado en 2004

A recommendation for revised dose calibrator measurement procedures for 89Zr and 124I

artículo científico publicado en 2014

A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography.

artículo científico publicado en 2003

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

artículo científico publicado en 2005

Biodistribution and radiation dose estimates for Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

article

Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy

artículo científico publicado en 2017

Bone marrow dosimetry using 124I-PET.

artículo científico publicado en 2012

CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging

artículo científico publicado en 2020

Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.

artículo científico publicado en 2005

Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.

artículo científico publicado en 2015

Copper-64 trastuzumab PET imaging: a reproducibility study

artículo científico publicado en 2016

Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250.

artículo científico publicado en 2011

Corrigendum to "Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia" [Neoplasia 11 (2009) 247-259]

artículo científico publicado en 2016

Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.

artículo científico publicado en 2009

Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.

artículo científico publicado en 2009

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

artículo científico publicado en 2016

First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

scientific article published on 04 October 2019

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy

artículo científico publicado en 2002

High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia

artículo científico publicado en 2010

Hypoxia in microscopic tumors.

artículo científico publicado en 2008

I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.

artículo científico publicado en 2018

Image deconvolution in digital autoradiography: a preliminary study

artículo científico publicado en 2008

Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats

artículo científico publicado en 2012

Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody

scientific article published on 03 May 2019

In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression

artículo científico publicado en 2009

Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors.

artículo científico publicado en 2015

Integrating Early Rapid Post-Peptide Receptor Radionuclide Therapy Quality Assurance Scan into the Outpatient Setting

scientific article published on 28 February 2019

Iodination of annexin V for imaging apoptosis.

artículo científico publicado en 2002

Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

artículo científico publicado en 2003

Mathematical model of 5-[125I]iodo-2′-deoxyuridine treatment: continuous infusion regimens for hepatic metastases ⬇️

artículo científico publicado el 15 de julio de 1998

Measurements of partial oxygen pressure pO2 using the OxyLite system in R3327-AT tumors under isoflurane anesthesia.

artículo científico publicado en 2006

Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer

artículo científico publicado en 2017

Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer

artículo científico publicado en 2017

Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

artículo científico publicado en 2009

Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam

scientific article published on 01 November 2000

PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer

artículo científico publicado en 2015

Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients

artículo científico publicado en 2019

Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer

artículo científico publicado en 2017

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

artículo científico publicado en 2019

Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer

artículo científico publicado en 2004

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

artículo científico publicado en 2007

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

artículo científico publicado en 2013

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

artículo científico publicado en 2017

Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.

scientific article published on December 2013

Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.

artículo científico publicado en 2013

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

artículo científico publicado en 2005

Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.

scientific article published on April 2008

Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer

artículo científico publicado en 2014

Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?

artículo científico publicado en 2009

Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.

artículo científico publicado en 2011

Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

artículo científico publicado en 2019

Safety and feasibility of PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer

scientific article published on 03 April 2020

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

artículo científico publicado en 2000

Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.

artículo científico publicado en 2015

Tumor Burden Assessment with Positron Emission Tomography with

artículo científico publicado en 2000

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma

artículo científico publicado en 2016

Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy

artículo científico publicado en 2007

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

artículo científico publicado en 2014

Lista de obras de Joseph A O'Donoghue

(124)I-huA33 antibody PET of colorectal cancer.

124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.

18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.

89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.

A recommendation for revised dose calibrator measurement procedures for 89Zr and 124I

A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography.

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

Biodistribution and radiation dose estimates for Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy

Bone marrow dosimetry using 124I-PET.

CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging

Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.

Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.

Copper-64 trastuzumab PET imaging: a reproducibility study

Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250.

Corrigendum to "Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia" [Neoplasia 11 (2009) 247-259]

Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.

Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy

High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia

Hypoxia in microscopic tumors.

I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.

Image deconvolution in digital autoradiography: a preliminary study

Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats

Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody

In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression

Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors.

Integrating Early Rapid Post-Peptide Receptor Radionuclide Therapy Quality Assurance Scan into the Outpatient Setting

Iodination of annexin V for imaging apoptosis.

Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

Mathematical model of 5-[125I]iodo-2′-deoxyuridine treatment: continuous infusion regimens for hepatic metastases ⬇️

Measurements of partial oxygen pressure pO2 using the OxyLite system in R3327-AT tumors under isoflurane anesthesia.

Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer

Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer

Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.

Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam

PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer

Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients

Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.

Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.

Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer

Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?

Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.

Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

Safety and feasibility of PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.

Tumor Burden Assessment with Positron Emission Tomography with

Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma

Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer